Carly Lasure, PA | |
350 N Wilmot Rd, Tucson, AZ 85711-2602 | |
(520) 873-3000 | |
Not Available |
Full Name | Carly Lasure |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 350 N Wilmot Rd, Tucson, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427797604 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 9354 (Arizona) | Secondary |
363A00000X | Physician Assistant | 9354 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Carly Lasure, PA 3658 W Lantana Hills Pl, Tucson, AZ 85741-1159 Ph: () - | Carly Lasure, PA 350 N Wilmot Rd, Tucson, AZ 85711-2602 Ph: (520) 873-3000 |
News Archive
Two years after undergoing a double mastectomy and chemotherapy so severe she was hospitalized in intensive care for several weeks, breast cancer survivor Denise Hicks should be following what her doctors call 'the plan' which includes additional medications and treatments.
"Eighty-six percent of HIV-positive people in the Democratic Republic of Congo [DRC] have no access to antiretrovirals, medical charity Doctors Without Borders said Wednesday," calling the "conditions of access to care for people living with HIV/AIDS ... catastrophic," Agence France-Presse reports.
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
The White House believes a successful rollout of the health law will help determine President Barack Obama's legacy, while Republicans appear equally intent on reaping political benefits by gutting this and other administration priorities.
Boosting the function of natural killer cells with magnetic nanoparticles could make cancer immunotherapy more efficient.
› Verified 1 days ago